Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 22, 2026 is 275.52 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 284.19 % — a change of -3.05% (lower).

Cash Conversion

275.52 %

YoY

-3.05%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Vcanbio Cell & Gene Engineering Corp is 2025 275.52 % . Cash Conversion Rate (OCF/Net Income) of Vcanbio Cell & Gene Engineering Corp was 2024 284.19 % . It decreases by -3.05% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
219.54 CNY
Jan 1, 2019
485.95 CNY
Jan 1, 2020
-192.61 CNY
Jan 1, 2021
206.64 CNY
Jan 1, 2022
231.79 CNY
Jan 1, 2023
280.89 CNY
Jan 1, 2024
284.19 CNY
Jan 1, 2025
275.52 CNY
The Vcanbio Cell & Gene Engineering Corp Cash Conversion history
YEARCash ConversionYoY
275.52 %-3.05%
284.19 %+1.17%
280.89 %+21.18%
231.79 %+12.17%
206.64 %-207.28%
-192.61 %-139.64%
485.95 %+121.35%
219.54 %-67.61%
677.85 %+78.63%
379.47 %+9,571.50%
3.92 %-99.37%
624.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Cash Conversion Rate (OCF/Net Income) of Vcanbio Cell & Gene Engineering Corp is 275.52 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Vcanbio Cell & Gene Engineering Corp changed from 284.19 % to 275.52 %, representing a -3.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Vcanbio Cell & Gene Engineering Corp with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Vcanbio Cell & Gene Engineering Corp

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Vcanbio Cell & Gene Engineering Corp